日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Hyperactive KRAS/MAPK signaling disrupts normal lymphatic vessel architecture and function

过度活跃的 KRAS/MAPK 信号会破坏正常的淋巴管结构和功能

Lorenzo M Fernandes #, Jeffrey Tresemer #, Jing Zhang, Jonathan J Rios, Joshua P Scallan, Michael T Dellinger

Trametinib inhibits lymphatic vessel invasion of bone in a mouse model of Gorham-Stout disease

曲美替尼抑制 Gorham-Stout 病小鼠模型中的淋巴管骨侵袭

Anna L McCarter, Michael T Dellinger

Heterozygous Mutation of Vegfr3 Reduces Renal Lymphatics without Renal Dysfunction

Vegfr3 杂合突变导致肾淋巴管减少,但不会导致肾功能障碍

Hao Liu, Chitkale Hiremath, Quinten Patterson, Saumya Vora, Zhiguo Shang, Andrew R Jamieson, Reto Fiolka, Kevin M Dean, Michael T Dellinger, Denise K Marciano

KRAS-driven model of Gorham-Stout disease effectively treated with trametinib

KRAS 驱动的 Gorham-Stout 病模型可通过曲美替尼有效治疗

Nassim Homayun-Sepehr, Anna L McCarter, Raphaël Helaers, Christine Galant, Laurence M Boon, Pascal Brouillard, Miikka Vikkula, Michael T Dellinger

Lymphatics in bone arise from pre-existing lymphatics

骨骼中的淋巴管源自先前存在的淋巴管

Marco Monroy, Anna L McCarter, Devon Hominick, Nina Cassidy, Michael T Dellinger

VEGF-C promotes the development of lymphatics in bone and bone loss

VEGF-C 促进骨骼淋巴系统发育和骨质流失

Devon Hominick #, Asitha Silva #, Noor Khurana, Ying Liu, Paul C Dechow, Jian Q Feng, Bronislaw Pytowski, Joseph M Rutkowski, Kari Alitalo, Michael T Dellinger

Mir-126 is a conserved modulator of lymphatic development

Mir-126 是淋巴发育的保守调节剂

Zacharias Kontarakis, Andrea Rossi, Sophie Ramas, Michael T Dellinger, Didier Y R Stainier

Identification of Gene Expression Differences between Lymphangiogenic and Non-Lymphangiogenic Non-Small Cell Lung Cancer Cell Lines

淋巴管生成和非淋巴管生成非小细胞肺癌细胞系之间基因表达差异的鉴定

Erin Regan, Robert C Sibley, Bercin Kutluk Cenik, Asitha Silva, Luc Girard, John D Minna, Michael T Dellinger

Collagen signaling enhances tumor progression after anti-VEGF therapy in a murine model of pancreatic ductal adenocarcinoma

在小鼠胰腺导管腺癌模型中,胶原信号增强抗 VEGF 治疗后的肿瘤进展

Kristina Y Aguilera, Lee B Rivera, Hoon Hur, Juliet G Carbon, Jason E Toombs, Courtney D Goldstein, Michael T Dellinger, Diego H Castrillon, Rolf A Brekken

RHOA-FAK is a required signaling axis for the maintenance of KRAS-driven lung adenocarcinomas

RHOA-FAK 是 KRAS 驱动的肺腺癌维持所需的信号轴

Georgia Konstantinidou, Giorgio Ramadori, Francesca Torti, Kim Kangasniemi, Rachel E Ramirez, Yiran Cai, Carmen Behrens, Michael T Dellinger, Rolf A Brekken, Ignacio I Wistuba, Adriana Heguy, Julie Teruya-Feldstein, Pier Paolo Scaglioni